NIAID initiates phase I study of a trispecific broadly neutralizing antibody against HIV May 6, 2019 No Comments
GlaxoSmithKline's GSK-2838232 shows activity in phase IIa study in patients with HIV March 11, 2019 No Comments
CROI 2019: With additional long-term remission, number of possible HIV cures doubles to 2 March 5, 2019 No Comments
RSS